Brünner N - Search Results

1

Intact and cleaved plasma soluble urokinase receptor in patients with metastatic colorectal cancer treated with oxaliplatin with or without cetuximab.

Tarpgaard LS, Christensen IJ, Høyer-Hansen G, Lund IK, Guren TK, Glimelius B, Sorbye H, Tveit KM, Nielsen HJ, Moreira JM, Pfeiffer P, Brünner N. Tarpgaard LS, et al. Among authors: brunner n. Int J Cancer. 2015 Nov 15;137(10):2470-7. doi: 10.1002/ijc.29476. Epub 2015 Mar 9. Int J Cancer. 2015. PMID: 25664394 Free article. Clinical Trial.

2

Prognostic significance of soluble urokinase plasminogen activator receptor in serum and cytosol of tumor tissue from patients with primary breast cancer.

Riisbro R, Christensen IJ, Piironen T, Greenall M, Larsen B, Stephens RW, Han C, Høyer-Hansen G, Smith K, Brünner N, Harris AL. Riisbro R, et al. Among authors: brunner n. Clin Cancer Res. 2002 May;8(5):1132-41. Clin Cancer Res. 2002. PMID: 12006529

3

Expression of urokinase plasminogen activator, its receptor and type-1 inhibitor in malignant and benign prostate tissue.

Usher PA, Thomsen OF, Iversen P, Johnsen M, Brünner N, Høyer-Hansen G, Andreasen P, Danø K, Nielsen BS. Usher PA, et al. Among authors: brunner n. Int J Cancer. 2005 Mar 1;113(6):870-80. doi: 10.1002/ijc.20665. Int J Cancer. 2005. PMID: 15515049 Free article.

4

TIMP-1 is significantly associated with objective response and survival in metastatic colorectal cancer patients receiving combination of irinotecan, 5-fluorouracil, and folinic acid.

Sørensen NM, Byström P, Christensen IJ, Berglund A, Nielsen HJ, Brünner N, Glimelius B. Sørensen NM, et al. Among authors: brunner n. Clin Cancer Res. 2007 Jul 15;13(14):4117-22. doi: 10.1158/1078-0432.CCR-07-0186. Clin Cancer Res. 2007. PMID: 17634538 Clinical Trial.

5

A novel prognostic index in colorectal cancer defined by serum carcinoembryonic antigen and plasma tissue inhibitor of metalloproteinases-1.

Nielsen HJ, Christensen IJ, Brünner N. Nielsen HJ, et al. Among authors: brunner n. Scand J Gastroenterol. 2010;45(2):200-7. doi: 10.3109/00365520903429406. Scand J Gastroenterol. 2010. PMID: 20095885

6

High plasma TIMP-1 and serum CEA levels during combination chemotherapy for metastatic colorectal cancer are significantly associated with poor outcome.

Aldulaymi B, Byström P, Berglund A, Christensen IJ, Brünner N, Nielsen HJ, Glimelius B. Aldulaymi B, et al. Among authors: brunner n. Oncology. 2010;79(1-2):144-9. doi: 10.1159/000320686. Epub 2010 Dec 8. Oncology. 2010. PMID: 21150229

7

Directions for further improvements of treatment of metastatic colorectal cancer.

Brünner N, Nielsen HJ. Brünner N, et al. Scand J Gastroenterol. 2012 Mar;47(3):363-4. doi: 10.3109/00365521.2012.640837. Epub 2011 Dec 19. Scand J Gastroenterol. 2012. PMID: 22181055 No abstract available.

8

TIMP-1 and CEA as biomarkers in third-line treatment with irinotecan and cetuximab for metastatic colorectal cancer.

Spindler KL, Christensen IJ, Nielsen HJ, Jakobsen A, Brünner N. Spindler KL, et al. Among authors: brunner n. Tumour Biol. 2015 Jun;36(6):4301-8. doi: 10.1007/s13277-015-3069-z. Epub 2015 Jan 23. Tumour Biol. 2015. PMID: 25608838

9

A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification.

Tarpgaard LS, Qvortrup C, Nygård SB, Nielsen SL, Andersen DR, Jensen NF, Stenvang J, Detlefsen S, Brünner N, Pfeiffer P. Tarpgaard LS, et al. Among authors: brunner n. BMC Cancer. 2016 Feb 11;16:91. doi: 10.1186/s12885-016-2124-5. BMC Cancer. 2016. PMID: 26867764 Free PMC article. Clinical Trial.

10

TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: a potential novel approach to the treatment of metastatic colorectal cancer.

Tarpgaard LS, Ørum-Madsen MS, Christensen IJ, Nordgaard C, Noer J, Guren TK, Glimelius B, Sorbye H, Ikdahl T, Kure EH, Tveit KM, Nielsen HJ, Pfeiffer P, Brünner N, Moreira JM. Tarpgaard LS, et al. Among authors: brunner n. Oncotarget. 2016 Sep 13;7(37):59441-59457. doi: 10.18632/oncotarget.11118. Oncotarget. 2016. PMID: 27509063 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

593 results

Search Page